[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335887-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335887-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","bacteria-based-nanoprobes-for-cancer-therapy-review-article","Bacteria-Based Nanoprobes for Cancer Therapy - review article","","Surgical removal remains a foundation of cancer treatment, yet chemotherapy and radiotherapy are limited by systemic toxicity, lack of selectivity, and resistance. Bacteria-derived systems and synthetic biological nanocarriers are presented as a promising alternative due to their ability to achieve intrinsic tumor targeting and to inhibit tumor growth through anti-cancer agents and immune responses. This review outlines the development, mechanisms, advantages, and limitations of bacteria-based nanoprobes, then summarizes recent progress in synergistic strategies and clinical trials.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/bacteria-based-nanoprobes-for-cancer-therapy-review-article/335887/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/bacteria-based-nanoprobes-for-cancer-therapy-review-article/335887.png","ImageObject",300,407,{"name":42,"@type":43},"Logic","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are surgery, chemotherapy, and radiotherapy not always sufficient for cancer treatment?","Question",{"text":63,"@type":64},"Even though they are standard pillars, chemotherapy and radiotherapy can cause systemic toxicity and resistance, and they may have reduced effectiveness in non-operative or advanced cases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does the EPR effect play in nanomedicine for cancer?",{"text":68,"@type":64},"The enhanced permeation and retention (EPR) effect describes how nanometric devices preferentially accumulate in tumoral tissues via tumor vasculature, giving nanomedicine an advantage over conventional approaches.",{"name":70,"@type":61,"acceptedAnswer":71},"How do bacteria-based nanoprobes aim to improve anti-cancer outcomes?",{"text":72,"@type":64},"They leverage intrinsic tumor targeting and combine anti-cancer agent delivery with immune response, often as part of bacteria-mediated synergistic therapeutic strategies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335887,1790219593,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article REVIEW  \nBacteria-Based Nanoprobes for Cancer Therapy  \nYiping Lu 1 , *, Nan Mei 1 , *, Yinwei Ying 1 , *, Dongdong Wang 1 , Xuanxuan Li 1 , Yajing Zhao 1 , Yuqi Zhu 1 , Shun Shen2 , 3 , Bo Yin 1  \n1Department of Radiology, Huashan Hospital, Fudan University, Shanghai, People’s Republic of China; 2Pharmacy Department, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, People’s Republic of China; 3Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Bo Yin; Shun Shen, [Email yinbo@fudan.edu.cn](Email yinbo@fudan.edu.cn); [nanocarries@gmail.com](nanocarries@gmail.com)  \n\n| Abstract: Surgical removal together with chemotherapy and radiotherapy has used to be the pillars of cancer treatment. Although these traditional methods are still considered as the first-line or standard treatments, non-operative situation, systemic toxicity or resistance severely weakened the therapeutic effect. More recently, synthetic biological nanocarriers elicited substantial interest and exhibited promising potential for combating cancer. In particular, bacteria and their derivatives are omnipotent to realize intrinsic tumor targeting and inhibit tumor growth with anti-cancer agents secreted and immune response. They are frequently employed in synergistic bacteria-mediated anticancer treatments to strengthen the effectiveness of anti-cancer treatment. In this review, we elaborate on the development, mechanism and advantage of bacterial therapy against cancer and then systematically introduce the bacteria-based nanoprobes against cancer and the recent achievements in synergistic treatment strategies and clinical trials. We also discuss the advantages as well as the limitations of these bacteria-based nanoprobes, especially the questions that hinder their application in human, exhibiting this novel anti-cancer endeavor comprehensively.\u003Cbr>Keywords: bacteria-based nanoprobe, bacteria-mediated synergistic cancer therapy, nanomedicine, tumor targeting, tumor immune microenvironment, clinical trial |\n| --- |\n| Introduction\u003Cbr>Nowadays, cancer is considered to rank as the leading cause of death and the single most important barrier to increasing life expectancy in every country of the world in the 21st century.1 Numerous efforts have been made to conquer cancers. Surgical resection with tumor removal is known as the first-line treatment of many kinds of tumors in their early stage, but for unresectable ones, additional tools are indispensable. Since the late 20th century, new methods, especially chemotherapy and radiotherapy, which utilizes different types of chemotherapeutic drugs or high doses of radiation, are applied to kill tumor cells and shrink tumors. When compared to chemotherapy, the utility of radiotherapy is rather limited since it is only suitable for a tumor confined to a discrete anatomical area.2 As a systemic therapy, chemotherapy with anti-tumor drugs is capable to treat cancer throughout the whole body even with metastasis.3 However, the therapeutic effect of chemotherapy is often modest. It was reported that cancer treatment based on a broad use of cytotoxic chemotherapy in unselected cancer patients had reached its therapeutic plateau.4 Furthermore, the systemic toxicity caused by the lack of selectivity and resistance to chemotherapy and radiotherapy had also severely hampered the effectiveness of these traditional treatments.5 Therefore, the need to find better treatment alternatives was underscored. The phenomenon of the selective accumulation of nanometric devices into tumoral tissues discovered first by Matsumura and Maeda in 1986, known as enhanced permeation and retention (EPR) effect, has given nanomedicine an advantage","cbCaivQH85iozzH5","https://ap.wps.com/l/cbCaivQH85iozzH5","pdf",9403595,27,"English","# Introduction\n## Cancer treatment limitations\n## Nanomedicine and the EPR effect\n## Nanoparticle drug delivery systems (DDSs)","[{\"question\":\"Why are surgery, chemotherapy, and radiotherapy not always sufficient for cancer treatment?\",\"answer\":\"Even though they are standard pillars, chemotherapy and radiotherapy can cause systemic toxicity and resistance, and they may have reduced effectiveness in non-operative or advanced cases.\"},{\"question\":\"What role does the EPR effect play in nanomedicine for cancer?\",\"answer\":\"The enhanced permeation and retention (EPR) effect describes how nanometric devices preferentially accumulate in tumoral tissues via tumor vasculature, giving nanomedicine an advantage over conventional approaches.\"},{\"question\":\"How do bacteria-based nanoprobes aim to improve anti-cancer outcomes?\",\"answer\":\"They leverage intrinsic tumor targeting and combine anti-cancer agent delivery with immune response, often as part of bacteria-mediated synergistic therapeutic strategies.\"}]","Bacteria-Based Nanoprobes for Cancer Therapy - review article | PDF",1790012726,68]